SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2017 | Mar2016 | Mar2015 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹20 Cr | ₹20 Cr | ₹11 Cr | ₹10 Cr | ₹9.76 Cr |
What is the latest Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹20 Cr |
Mar2022 | ₹20 Cr |
Mar2017 | ₹11 Cr |
Mar2016 | ₹10 Cr |
Mar2015 | ₹9.76 Cr |
How is Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹20 Cr | 1.42 | |
Mar2022 | ₹20 Cr | 87.87 | |
Mar2017 | ₹11 Cr | 1.72 | |
Mar2016 | ₹10 Cr | 6.14 | |
Mar2015 | ₹9.76 Cr | - |
Compare Consolidated Net Profit of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,271.8 Cr | -2.3% | 9.9% | 128.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -2.3% |
9.9% |
128.3% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses